Amyris, Inc. AMRS was a big mover last session, as its shares rose over 17% on the day. The move came after the company achieved record first-quarter product sales for its Biossance brand. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of 44 cents to 53 cents in the past one-month time frame.
None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Amyris currently carries a Zacks Rank #5 (Strong Sell) while its Earnings ESP is negative.
Amyris, Inc. Price
Amyris, Inc. Price | Amyris, Inc. Quote
A better-ranked stock in the Biofuels space is Aemetis, Inc. AMTX, carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is AMRS going up? Or down? Predict to see what others think: Up or Down
The Best & Worst of Zacks
Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +25% per year. Plus, you may download 220 Zacks Rank #5 "Strong Sells." Even though this list holds many stocks that seem to be solid, it has historically performed 6X worse than the market. See these critical buys and sells free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amyris, Inc. (AMRS): Free Stock Analysis Report
Aemetis, Inc (AMTX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research